Duplications in the G3 domain or switch II region in HRAS identified in patients with Costello syndrome
- PMID: 34618388
- DOI: 10.1002/humu.24287
Duplications in the G3 domain or switch II region in HRAS identified in patients with Costello syndrome
Abstract
Costello syndrome (CS) is an autosomal-dominant disorder characterized by distinctive facial features, hypertrophic cardiomyopathy, skeletal abnormalities, intellectual disability, and predisposition to cancers. Germline variants in HRAS have been identified in patients with CS. Intragenic HRAS duplications have been reported in three patients with a milder phenotype of CS. In this study, we identified two known HRAS variants, p.(Glu63_Asp69dup), p.(Glu62_Arg68dup), and one novel HRAS variant, p.(Ile55_Asp57dup), in patients with CS, including a patient with craniosynostosis. These intragenic duplications are located in the G3 domain and the switch II region. Cells expressing cDNA with these three intragenic duplications showed an increase in ELK-1 transactivation. Injection of wild-type or mutant HRAS mRNAs with intragenic duplications in zebrafish embryos showed significant elongation of the yolk at 11 h postfertilization, which was improved by MEK inhibitor treatment, and a variety of developmental abnormalities at 3 days post fertilization was observed. These results indicate that small in-frame duplications affecting the G3 domain and switch II region of HRAS increase the activation of the ERK pathway, resulting in developmental abnormalities in zebrafish or patients with CS.
Keywords: Costello syndrome; G3 domain; HRAS; intragenic duplication; switch II region.
© 2021 Wiley Periodicals LLC.
References
REFERENCES
-
- Addissie, Y. A., Kotecha, U., Hart, R. A., Martinez, A. F., Kruszka, P., & Muenke, M. (2015). Craniosynostosis and Noonan syndrome with KRAS mutations: Expanding the phenotype with a case report and review of the literature. American Journal of Medical Genetics, Part A, 167A(11), 2657-2663. https://doi.org/10.1002/ajmg.a.37259
-
- Anastasaki, C., Estep, A. L., Marais, R., Rauen, K. A., & Patton, E. E. (2009). Kinase-activating and kinase-impaired cardio-facio-cutaneous syndrome alleles have activity during zebrafish development and are sensitive to small molecule inhibitors. Human Molecular Genetics, 18(14), 2543-2554. https://doi.org/10.1093/hmg/ddp186
-
- Aoki, K., Kumagai, Y., Sakurai, A., Komatsu, N., Fujita, Y., Shionyu, C., & Matsuda, M. (2013). Stochastic ERK activation induced by noise and cell-to-cell propagation regulates cell density-dependent proliferation. Molecular Cell, 52(4), 529-540. https://doi.org/10.1016/j.molcel.2013.09.015
-
- Aoki, Y., Niihori, T., Banjo, T., Okamoto, N., Mizuno, S., Kurosawa, K., Ogata, T., Takada, F., Yano, M., Ando, T., Hoshika, T., Barnett, C., Ohashi, H., Kawame, H., Hasegawa, T., Okutani, T., Nagashima, T., Hasegawa, S., Funayama, R., … Matsubara, Y. (2013). Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome. American Journal of Human Genetics, 93(1), 173-180. https://doi.org/10.1016/j.ajhg.2013.05.021
-
- Aoki, Y., Niihori, T., Inoue, S., & Matsubara, Y. (2016). Recent advances in RASopathies. Journal of Human Genetics, 61(1), 33-39. https://doi.org/10.1038/jhg.2015.114
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous